Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Heart rate, Heart rate increased, High density lipoprotein, Low density lipoprotein
Clinical narrative: heart rate: (12Mar2021): 139; cholesterol 200 mg/dL/ 251 mg/dL; Hemoglobin A1c 6.5 %/ 7.0%; LDL Chol Cale (NIH) 126 mg/dl/ 174mg/dL; glucose 133  mg/dL/ 166 mg/dL; ALT(SGPT)46 IU/L/ 48 IU/l; electrocardiogram: (12Mar2021) abnormal; triglycerides 169mg/dL; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 09Mar2021 (Lot number: EN4202) at the age of 71 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEART RATE INCREASED (medically significant) with onset 12Mar2021, outcome "unknown", described as "heart rate: (12Mar2021): 139"; BLOOD CHOLESTEROL INCREASED (non-serious) with onset 12Mar2021, outcome "unknown", described as "cholesterol 200 mg/dL/ 251 mg/dL"; GLYCOSYLATED HAEMOGLOBIN INCREASED (non-serious) with onset 12Mar2021, outcome "unknown", described as "Hemoglobin A1c 6.5 %/ 7.0%"; BLOOD TRIGLYCERIDES INCREASED (non-serious) with onset Mar2021, outcome "unknown", described as "triglycerides 169mg/dL"; LOW DENSITY LIPOPROTEIN INCREASED (non-serious) with onset 12Mar2021, outcome "unknown", described as "LDL Chol Cale (NIH) 126 mg/dl/ 174mg/dL"; BLOOD GLUCOSE INCREASED (non-serious) with onset 12Mar2021, outcome "unknown", described as "glucose 133  mg/dL/ 166 mg/dL"; ALANINE AMINOTRANSFERASE INCREASED (non-serious) with onset 12Mar2021, outcome "unknown", described as "ALT(SGPT)46 IU/L/ 48 IU/l"; ELECTROCARDIOGRAM ABNORMAL (non-serious) with onset 12Mar2021, outcome "unknown", described as "electrocardiogram: (12Mar2021) abnormal". The patient underwent the following laboratory tests and procedures: alanine aminotransferase (0-32): (12Mar2021) 46 IU/l; (12Mar2021) 48 IU/l; albumin globulin ratio (1.2-2.2): (12Mar2021) 1.7; (12Mar2021) 1.8; aspartate aminotransferase (0-40): (12Mar2021) 28 IU/l; (12Mar2021) 29 IU/l; blood albumin (3.7-4.7): (12Mar2021) 4.4 g/l; (12Mar2021) 4.5 g/l; blood alkaline phosphatase (48-121): (12Mar2021) 97 IU/l; (12Mar2021) 88 IU/l; blood bilirubin (0.0-1.2): (12Mar2021) 0.3 mg/dl; (12Mar2021) 0.5 mg/dl; blood calcium (8.7-10.3): (12Mar2021) 9.8 mg/dl; (12Mar2021) 9.9 mg/dl; blood chloride (96-106): (12Mar2021) 100 mmol/L; (12Mar2021) 103 mmol/L; blood cholesterol (100-199): (12Mar2021) 162 mg/dl; (12Mar2021) 200 mg/dl; (Mar2021) 251 mg/dl; blood creatinine (0.57-1.00): (12Mar2021) 0.76 mg/dl; (12Mar2021) 0.95 mg/dl; blood glucose (65-99): (12Mar2021) 133 mg/dl, notes: Flag: High; (12Mar2021) 166 mg/dl, notes: Flag: High; blood potassium (3.5-5.2): (12Mar2021) 4.7 mmol/L; (12Mar2021) 4.6 mmol/L; blood pressure measurement: (12Mar2021) 117/58; (12Mar2021) 146/76; blood sodium (134-144): (12Mar2021) 143 mmol/L; (12Mar2021) 140 mmol/L; blood triglycerides (0-149): (12Mar2021) 94 mg/dl; (12Mar2021) 110 mg/dl; (Mar2021) 169 mg/dl; blood urea nitrogen/creatinine ratio (12-28): (12Mar2021) 17; (12Mar2021) 18; carbon dioxide (20-29): (12Mar2021) 25 mmol/L; (12Mar2021) 26 mmol/L; electrocardiogram: (12Mar2021) abnormal; globulin (1.5-4.5): (12Mar2021) 2.6 g/dl; (12Mar2021) 2.5 g/dl; glomerular filtration rate: (12Mar2021) 91; (12Mar2021) 70; glycosylated haemoglobin increased (4.8-5.6): (12Mar2021) 7.1 %; (12Mar2021) 6.5 %; heart rate: (12Mar2021) 82; (12Mar2021) 139; high density lipoprotein: (12Mar2021) 48 mg/dl; (12Mar2021) 54 mg/dl; (Mar2021) 46 mg/dl; low density lipoprotein (0-99): (12Mar2021) 97 mg/dl; (12Mar2021) 126 mg/dl; (Mar2021) 174 mg/dl; oxygen saturation: (12Mar2021) 97; (12Mar2021) 96; protein total (6.0-8.5): (12Mar2021) 7.0 g/dl; (12Mar2021) 7.0 g/dl; very low density lipoprotein (5-40): (12Mar2021) 17 mg/dl; (12Mar2021) 20 mg/dl.